Author: healthadmin
Imagine a mouse rapidly and intermittently sniffing the crumbs it finds while foraging. Now compare it to a human bending down and taking one deep breath to determine if a cantaloupe is ripe. A new study from Northwestern University has found that just like humans, mice can intentionally explore their environment with just one sniff. This is something scientists didn’t know before. Two new complementary studies from Northwestern University will be published together on July 3. scientific progressstudied olfaction from opposite sides and found that rodents and humans rely on the same basic neurophysiology to process odors: motor and rhythmic…
According to a study published in Psychology of Aesthetics, Creativity, and the Arts, professional visual artists have unique brain structures and activity patterns that appear to support the vivid mental imagery needed to create art. Most people can draw, paint, or sketch to some extent, but only a few develop the expertise necessary to become a professional artist. Scientists have long been interested in creativity, but little is known about how years of artistic training affect the brain. Previous research has identified brain networks involved in idea generation and refinement, but most research has focused on creativity in ordinary people…
Microplastic fears have dominated social media, news, and public conversations in recent years, and concerns about their impact on human health continue to grow. For runners, avoiding plastic is nearly impossible. Used in water bottles, energy gel packaging, shoes, apparel, and more. But how do microplastics actually affect us? And are we at higher risk for exposure to them? We spoke to experts about the science behind the presence of plastics in running shoes and their potential health effects. The dangers of microplastics Microplastics pose risks to both human health and the environment. Sharon Dodd A family physician in Richmond,…
An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown promising initial results when used in combination with standard first-line chemotherapy, according to research presented today at the ESMO Gastrointestinal Cancer Conference 2026. A phase I/II multicenter study led by researchers at Dana-Farber Cancer Institute in Boston evaluated zordonrasib in patients with metastatic pancreatic cancer whose tumors carry the KRAS G12D mutation. Initial findings showed high tumor shrinkage rates, significant reductions in cancer DNA detected in the bloodstream, and no unexpected safety concerns. Pancreatic cancer is one of the most deadly…
As carbon dioxide (CO2) emissions continue to rise, interest in geoengineering is growing as governments, researchers, and environmental advocacy groups seek ways to limit the worst effects of climate change. These large-scale climate interventions could affect rainfall, agriculture, and ecosystems around the world, and their potential benefits and risks are equally important. A new study by climate scientists at the University of California, Santa Barbara suggests that not all geoengineering strategies produce the same results. One of the proposed methods could significantly disrupt one of Earth’s most important climate cycles, while another appears to have little effect. The survey results…
July 7-10, 2026 | Geneva Dr. Alex Aliper, co-founder and president of Insilico Medicine, will be attending the AI for Good Global Summit 2026 on July 7 in Geneva, Switzerland. He will participate in a panel discussion titled “AI for Good Global Summit 2026.” “Expanding medical access through AI-powered science” From 14:30 to 15:00. After this, from 3:30 p.m. “Generative AI for drug discovery and pharmaceutical research and development” At the summit workshop: “AI for Manufacturing: Pharmaceutical Industry Workshop on Innovation, Applications and Standards” About the AI for Good Global Summit Organized by the International Telecommunication Union (ITU) in collaboration…
Researchers led by Frankfurt Medical University and Goethe University Frankfurt have identified how particularly aggressive lymphomas are recognized. By combining genetic and proteomic analyses, scientists were able to identify the biological characteristics of tumors, especially in high-risk patients who have little chance of cure with standard treatments. In the future, such patients will have direct access to more effective alternative treatments. Additionally, laboratory studies have provided the first clues to potential therapeutic targets. Diffuse large B-cell lymphoma (DLBCL), with more than 150,000 new cases worldwide each year, is the most common aggressive lymphoma. After diagnosis, patients usually receive a standard…
Escherichia coli (E. coli) is a mostly harmless bacterium that lives in the intestines of animals and humans. E. coli is the most well-studied bacterium, and when scientists discover something about E. coli, they often apply that discovery to all bacteria. So when scientists learned that E. coli allocates its resources to multiply as quickly as the environment allows, it was assumed that all bacteria behave similarly. But researchers at the University of California, San Diego have discovered that B. subtilis, a bacterium commonly found in soil, employs a different survival strategy. The results, published in the journal Science, raise…
Seventy years ago, London was suffocating. For five days in December 1952, toxic smog blanketed the city. My vision collapsed. Transport failed. Thousands died. It wasn’t a natural disaster. It was a product of policy failure. Out of this disaster was born the Clean Air Act 1956, one of the most important environmental laws in British history. This was a turning point. This study showed that science, when taken seriously, can transform public health. But the story didn’t end in 1956. Because the same forces that delayed action then continue to shape air pollution policy today. The Clean Air Act…
Blood tests could help identify which patients with colorectal cancer that has spread to the liver are most likely to benefit from postoperative chemotherapy, according to research presented today at the ESMO Gastrointestinal Cancer Conference 2026. The Phase II GALAXY study was led by researchers at Hyogo School of Medicine in Japan and collaborators including the University of Oxford in the UK. The study found that among patients who underwent upfront surgery and had circulating tumor DNA (ctDNA) detected postoperatively, those who received adjuvant chemotherapy had a significantly better prognosis than those who did not. At 4 years after surgery,…